News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Fujifilm Corporation has made an additional US$850m investment to enable the expansion of its BIO-CMDO sites in the UK, at Billingham, and in the US.
Vaccine company Valneva has been awarded Breakthrough Therapy Designation for its single-shot chikungunya vaccine candidate, VLA1553, by the US Food and Drug Administration (FDA).
Moderna has dosed the first participants in a Phase 1/2 study for mRNA-1010: its first quadrivalent seasonal influenza mRNA vaccine candidate.